Literature DB >> 26038285

Current structural biology of the heparin interactome.

Vitor H Pomin1, Barbara Mulloy2.   

Abstract

Heparin is the best known therapeutically active carbohydrate. It can bind and regulate multiple functional proteins such as coagulation cofactors, chemokines, and growth factors. This versatility has led to the recently developed concept of the heparin interactome--a group of proteins that, as the name implies, interact with heparin. The heparin interactome is structurally and functionally diverse. Though natural ligands of this class of proteins may be any of the glycosaminoglycans however, their structural biology is generally studied using heparin as a model compound. NMR spectroscopy contributes significantly to structural investigations of the resultant complexes in solution. This review aims therefore at discussing the current status in structural biology of the molecular complexes formed between heparin and its protein partners through the current concept of the heparin interactome.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26038285     DOI: 10.1016/j.sbi.2015.05.007

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  24 in total

1.  3-O sulfation of heparin leads to hepatotropism and longer circulatory half-life.

Authors:  Colton M Miller; Yongmei Xu; Katrina M Kudrna; Blake E Hass; Brianna M Kellar; Andrew W Egger; Jian Liu; Edward N Harris
Journal:  Thromb Res       Date:  2018-05-17       Impact factor: 3.944

Review 2.  Glycosaminoglycanomics: where we are.

Authors:  Sylvie Ricard-Blum; Frédérique Lisacek
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

3.  Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS.

Authors:  Jerusha Naidoo; Lisa M Stanek; Kousaku Ohno; Savanah Trewman; Lluis Samaranch; Piotr Hadaczek; Catherine O'Riordan; Jennifer Sullivan; Waldy San Sebastian; John R Bringas; Christopher Snieckus; Amin Mahmoodi; Amir Mahmoodi; John Forsayeth; Krystof S Bankiewicz; Lamya S Shihabuddin
Journal:  Mol Ther       Date:  2018-07-12       Impact factor: 11.454

4.  Glycosaminoglycans from fish swim bladder: isolation, structural characterization and bioactive potential.

Authors:  Yongxi Pan; Peipei Wang; Fuming Zhang; Yanlei Yu; Xing Zhang; Lei Lin; Robert J Linhardt
Journal:  Glycoconj J       Date:  2017-11-10       Impact factor: 2.916

Review 5.  Glycosaminoglycan Interactions Fine-Tune Chemokine-Mediated Neutrophil Trafficking: Structural Insights and Molecular Mechanisms.

Authors:  Krishna Rajarathnam; Krishna Mohan Sepuru; Prem Raj B Joseph; Kirti V Sawant; Aaron J Brown
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

Review 6.  So you think computational approaches to understanding glycosaminoglycan-protein interactions are too dry and too rigid? Think again!

Authors:  Nehru Viji Sankaranarayanan; Balaji Nagarajan; Umesh R Desai
Journal:  Curr Opin Struct Biol       Date:  2018-01-09       Impact factor: 6.809

7.  Structural basis of chemokine interactions with heparan sulfate, chondroitin sulfate, and dermatan sulfate.

Authors:  Krishna Mohan Sepuru; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2019-08-27       Impact factor: 5.157

8.  Glycosaminoglycans from chicken muscular stomach or gizzard.

Authors:  Yin Chen; Megan Reddy; Yanlei Yu; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2016-10-17       Impact factor: 2.916

9.  Evaluation of top-down mass spectrometry and ion-mobility spectroscopy as a means of mapping protein-binding motifs within heparin chains.

Authors:  Yunlong Zhao; Igor A Kaltashov
Journal:  Analyst       Date:  2020-04-14       Impact factor: 4.616

10.  Integrated Approach to Identify Heparan Sulfate Ligand Requirements of Robo1.

Authors:  Chengli Zong; Rongrong Huang; Eduard Condac; Yulun Chiu; Wenyuan Xiao; Xiuru Li; Weigang Lu; Mayumi Ishihara; Shuo Wang; Annapoorani Ramiah; Morgan Stickney; Parastoo Azadi; I Jonathan Amster; Kelley W Moremen; Lianchun Wang; Joshua S Sharp; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2016-09-27       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.